Drug Profile
ONO 1505
Alternative Names: ONO BF11301Latest Information Update: 11 Sep 2003
Price :
$50
*
At a glance
- Originator Ono Pharmaceutical; Scherer Healthcare
- Class Anti-ischaemics; Imidazoles; Small molecules; Vasodilators
- Mechanism of Action Thromboxane synthase inhibitors; Type 5 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Diabetic complications; Ischaemic heart disorders
Most Recent Events
- 08 Jun 2001 No-Development-Reported for Diabetic complications in United Kingdom (Unknown route)
- 09 Jul 1998 Biofor is now part of Scherer Healthcare
- 16 May 1997 Preclinical development for Diabetic complications in United Kingdom (Unknown route)